About
Rare Disease Treatments
Areas of Focus
Categories
BioinformaticsNorth & South Carolina
Clinical Trials (12)
View allTotal Trials
12
As Lead Sponsor
3
As Collaborator
9
Total Enrollment
613
By Phase
PHASE1/PHASE2: 2PHASE2: 1PHASE4: 7NA: 1PHASE2/PHASE3: 1
By Status
COMPLETED: 10NOT_YET_RECRUITING: 1RECRUITING: 1
Clinical Trials Pipeline12 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT07136181Lead Sponsor
Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma
PHASE1/PHASE2Not yet recruiting
36 participants
Started: Oct 31, 2025 · Completed: May 30, 2029
NCT06012695Lead Sponsor
NBM-BMX Administered Orally to Patients with Solid Tumors or Newly Diagnosed Glioblastoma
PHASE1/PHASE2Recruiting
79 participants
Started: Aug 11, 2023 · Completed: Sep 30, 2029
NCT01469767Collaborator
Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis
PHASE2Completed
10 participants
Started: Feb 1, 2012 · Completed: Aug 17, 2013
NCT01401803Collaborator
Brow Lifting With Dysport
PHASE4Completed
24 participants
Started: Sep 30, 2011 · Completed: Dec 31, 2012
NCT01186835Collaborator
Treatment of Forehead/Glabellar Rhytide Complex With Combination Botulinum Toxin A and Hyaluronic Acid Versus Botulinum Toxin A Injection Alone
NACompleted
20 participants
Started: Feb 28, 2011 · Completed: Jun 30, 2011
Locations (1)
Headquarters
Raleigh, NC, United States
Map
Loading map...